Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Filter Contract Award

20 Dec 2011 09:45

RNS Number : 3098U
Avon Rubber PLC
20 December 2011
 



20 December 2011

FILTER CONTRACT AWARD

Avon is pleased to announce that it has received a 5 year contract from the Department of Defense (DoD) for the supply of spare filters for its M50 respirator. Like previous contracts for spare filters, the contract is an Indefinite Delivery Indefinite Quantity ("IDIQ") contract and has a maximum order quantity of 2.4m filter pairs per year and 12m filter pairs over the contract term. The contract also allows the DoD to extend the term by 2 further option years, potentially extending the duration to 7 years. An initial order has been placed by the DoD with a value of $2.5m for immediate delivery.

This new contract is in addition to the existing sole source $38m, 3 year IDIQ contract announced in August. Avon has also received a further delivery order against this contact with a value of $6.1m for delivery by 1 April 2012.

As expected, the DoD has chosen to dual source the procurement of spare filters and another source has also been selected for a 5 year contract award. The Directors believe that it will take up to 2 years for a comparable product to be developed and approved, after which orders for filters for the M50 mask will be competitively bid. The supply of filters with M50 mask systems will remain sole sourced to Avon.

Commenting on the news, Peter Slabbert, Chief Executive said: "We are delighted to have been awarded this new contract which confirms Avon's position as a supplier of consumable filters to the DoD for a further 5 to 7 years. The procurement of the filter for the M50 mask from another supplier was expected and we believe that our state of the art manufacturing capability, our existing technology advantage and the continuation of the sole source window for up to another 2 years will allow Avon to retain its competitive advantage. We are also committed to widening our capability and product range in the area of filtration to enable us to continue to grow this repeat revenue stream."

For further enquiries, please contact:

Avon Rubber p.l.c.

Peter Slabbert, Chief Executive

01225 896 870

Andrew Lewis, Group Finance Director

01225 896 830

Fiona Stewart, Corporate Communications Executive

01225 896 871

Weber Shandwick Financial

Nick Oborne

020 7067 0700

Stephanie Badjonat

020 7067 0700

 

NOTES TO EDITORS: Avon Rubber p.l.c. is a world leader in the design, test and manufacture of advanced Chemical, Biological, Radiological and Nuclear (CBRN) respiratory protection solutions to the worlds military, law enforcement, first responder, emergency services, fire and industrial markets. Avon has a unique capability in CBRN protection based on a range of advanced CBRN technologies in respirator design, filtration and compressed air breathing apparatus. This enables Avon to develop specialised solutions that take full account of user requirements. Avon also owns a world leading dairy business manufacturing liners and tubing for the automated milking process. For further information please visit the Group's website www.avon-rubber.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTGCBDDRDDBGBG
Date   Source Headline
30th Jan 20207:00 amRNSAnnual General Meeting - Trading Update
24th Jan 20204:00 pmRNSHolding(s) in Company
23rd Jan 20204:00 pmRNSHolding(s) in Company
13th Jan 20204:00 pmRNSHolding(s) in Company
9th Jan 20202:00 pmRNSHolding(s) in Company
7th Jan 20203:00 pmRNSDirectors'/PDMR Shareholdings
2nd Jan 20205:00 pmRNSHolding(s) in Company
2nd Jan 20203:00 pmRNSAcquisition Update
23rd Dec 20194:41 pmRNSSecond Price Monitoring Extn
23rd Dec 20194:35 pmRNSPrice Monitoring Extension
23rd Dec 20197:00 amRNSAcquisition Update
19th Dec 20193:00 pmRNSHolding(s) in Company
16th Dec 20195:00 pmRNSHolding(s) in Company
10th Dec 20193:00 pmRNSNotice of Annual Report and Accounts and AGM
6th Dec 20198:00 amRNSDirector/PDMR Shareholding
29th Nov 201912:00 pmRNSDirector/PDMR Shareholding
28th Nov 20193:07 pmRNSHolding(s) in Company
21st Nov 20195:00 pmRNSHolding(s) in Company
13th Nov 20197:00 amRNSFinal Results
6th Nov 201911:00 amRNSHolding(s) in Company
6th Nov 201911:00 amRNSDirectors/PDMR Shareholdings
16th Oct 20197:00 amRNSNotice of Results
10th Oct 20195:00 pmRNSNotification of transaction of PDMR
9th Oct 201912:00 pmRNSDirectors'/PDMR Shareholding
27th Sep 20195:00 pmRNSHolding(s) in Company
26th Sep 20194:00 pmRNSNotification of transaction of PDMR
20th Sep 20192:00 pmRNSHolding(s) in Company
16th Sep 20197:00 amRNSPre-close trading update
13th Sep 20199:00 amRNSHolding(s) in Company
6th Sep 201912:00 pmRNSDirector/PDMR Shareholdings
30th Aug 20193:00 pmRNSHolding(s) in Company
22nd Aug 20194:00 pmRNSHolding(s) in Company
9th Aug 20197:00 amRNSHolding(s) in Company
7th Aug 201912:00 pmRNSDirector/PDMR Shareholding
7th Aug 20197:00 amRNSAcquisition of 3M's Ballistic-Protection Business
10th Jul 20192:00 pmRNSDirector/PDMR Shareholding
4th Jul 20195:00 pmRNSDirector Declaration
17th Jun 20192:00 pmRNSHolding(s) in Company
11th Jun 20197:00 amRNSAppointment of Joint Corporate Broker
6th Jun 20195:00 pmRNSDirector/PDMR Shareholding
3rd Jun 201910:00 amRNSHolding(s) in Company
8th May 20195:00 pmRNSDirector/PDMR Shareholding
3rd May 201912:00 pmRNSHolding(s) in Company
2nd May 20199:00 amRNSDirector/PDMR Shareholding
1st May 20197:00 amRNSHalf-year Report
24th Apr 201912:00 pmRNSMask system contract award
10th Apr 20198:00 amRNSDirector/PDMR Shareholding
2nd Apr 20197:00 amRNSNotice of Results
28th Mar 20197:00 amRNSM53A1 Contract
26th Mar 20197:00 amRNSUS DoD M53A1 Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.